HemaCare Co. (OTCMKTS:HEMA – Get Free Report) was up 0.6% on Thursday. The stock traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares were traded during trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6%
The business’s 50 day moving average price is $25.31 and its 200-day moving average price is $25.31.
HemaCare Company Profile
HemaCare Corporation was a biotechnology company that supplied human-derived biological materials for research and drug development. Its offerings included blood components, primary human cells, and other biospecimens used in studies involving immunology, cell therapy, gene therapy, regenerative medicine, and related life sciences applications.
The company worked with pharmaceutical, biotechnology, academic, and medical research organizations, providing donor-derived materials and collection services designed to support preclinical research and the development of advanced therapies.
See Also
- Five stocks we like better than HemaCare
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
